This Gut Bug May Help Control Blood Sugar and Curb Weight Gain
We’ve said it before…
Not all probiotics are created equal.
Some support digestion. Others boost immunity. And now, researchers say one particular strain may help you take control of your blood sugar—and your waistline.
A preclinical study out of Kyoto University has uncovered a surprising potential ally in the fight against obesity and insulin resistance: Streptococcus salivarius.
This naturally occurring bacterium—already found in the human mouth and upper respiratory tract—might also be the key to unlocking better blood sugar balance, even in the face of a high-fat diet.
What makes S. salivarius so special?
This probiotic powerhouse has a unique ability to convert dietary sucrose (a form of sugar) into exopolysaccharides (EPS)—complex carbohydrates that humans can’t digest.
While that may sound unhelpful at first, EPS serve as fuel for beneficial gut bacteria that can digest them, leading to a cascade of positive metabolic effects.
Once fermented by microbes like Bacteroides, these exopolysaccharides are transformed into short-chain fatty acids (SCFAs) like acetate and propionate—compounds known to help regulate blood sugar, reduce fat accumulation, and improve insulin sensitivity.
In other words: S. salivarius helps your gut turn excess sugar into metabolic gold.
In this preclinical study, researchers began by screening samples from 470 human donors. They discovered that individuals with lower body mass indexes (BMI) had higher levels of S. salivarius, while obese individuals had significantly less.
That alone piqued their interest. But what happened next was even more compelling.
When researchers gave high-fat-diet-induced obese mice a dose of EPS produced by S. salivarius, the mice experienced:
- Less weight gain
- Lower fat accumulation
- Improved blood glucose levels
Compared to the control group, the probiotic-fed mice were metabolically healthier—despite eating the same fat-rich diet.
That’s a major win, particularly in a world where managing sugar intake is a constant uphill battle.
Let’s face it: the modern diet isn’t kind to your metabolic system.
Between added sugars in processed foods and sedentary lifestyles, obesity and type 2 diabetes are on the rise. That’s why scientists are exploring every angle—including the microbiome—to find new ways to fight back.
And this study puts S. salivarius on the map as a promising new candidate in probiotic research aimed at blood sugar control and weight management.
This discovery also aligns with earlier EA discussions on how the gut microbiome can influence glucose metabolism—offering natural alternatives to medications like Ozempic.
In fact, by feeding certain gut bugs (rather than bypassing them with synthetic drugs), you may be able to encourage your body to regulate hunger, fat storage, and insulin response all on its own.
This was a preclinical study, so we’re not at the supplement shelf just yet. More human trials are needed to confirm these benefits outside the lab.
But researchers have already identified the exact genes responsible for the EPS-producing abilities of S. salivarius, which means formulation and targeted delivery are within reach.
And while you can’t buy a probiotic labeled S. salivarius for metabolic health—at least not yet—you can start thinking differently about sugar, gut health, and how the right microbial support may shape your body’s response to both.
We often blame sugar for metabolic dysfunction. But this study reminds us that how our gut handles sugar might be just as important as how much we consume.
If scientists can harness the natural power of S. salivarius, the future of blood sugar support may come in the form of a daily probiotic—not another prescription.
To the power of probiotics,
Rachel Mace
Managing Editorial Director, e-Alert
with contributions from the research team
Sources:
Probiotic May Have Blood Sugar Benefits: Preclinical Study. (2025, April 23). Nutraceuticals World. https://www.nutraceuticalsworld.com/breaking-news/probiotic-may-have-blood-sugar-benefits-preclinical-study/


